FDA Approves Imlygic (Talimogene Laherparepvec) for Melanoma
The US Food and Drug Administration (FDA) has approved a first-of-its kind treatment for melanoma tumors in the skin and lymph nodes that can’t be removed completely by surgery.
Melanoma Skin Cancer Rates are on the Rise
If rates of melanoma continue to increase at the current pace, 112,000 new cases will be diagnosed in 2030, according to a report by the Centers for Disease Control and Prevention (CDC).
4 Cancer Screening Tests for Men
Celebrate the fathers in your life this June by encouraging them to protect their health by getting up to date on cancer screening tests.
How to Spot Skin Cancer
Skin cancer is by far the most common type of cancer. If you know what to look for, you can spot warning signs of skin cancer early.
FDA Approves Keytruda (pembrolizumab) for Melanoma
The US Food and Drug Administration (FDA) has approved a new kind of immunotherapy drug, Keytruda (pembrolizumab), to treat melanoma skin cancer.
Surgeon General Calls for Action to Prevent Skin Cancer
The US Surgeon General’s office is drawing national attention to skin cancer, calling it a major public health problem that requires immediate action.
Deadly Myths About Skin Cancer
Many people are unaware of skin cancer's dangers, and they may be underestimating their risks. Here we bust some common myths about this very common form of cancer so that you can be in the know – and protect your health.
Report: Number of Cancer Survivors Continues to Grow
A new report by the American Cancer Society – in collaboration with the National Cancer Institute – estimates there are almost 14.5 million cancer survivors alive in the US today, and that number will grow to almost 19 million by 2024.
FDA Requires Warning on Tanning Beds
The US Food and Drug Administration (FDA) says people under age 18 should not use tanning booths/beds or sunlamps, and these products will now have to carry a warning stating that. These devices have been re-classified as moderate risk (Class II) instead of low risk (Class I).
Advancements in Immunotherapy for Melanoma Skin Cancer
Researchers studying immunotherapy drugs have made progress that may soon lead to improved treatments for people with advanced melanoma.
FDA Approves 2 New Melanoma Drugs
The US Food and Drug Administration (FDA) has approved 2 new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), to treat melanoma that has spread or that can’t be surgically removed.
The FDA Proposes Warning Labels for Tanning Beds
The US Food and Drug Administration (FDA) has issued a proposal to reclassify tanning beds and sunlamps and require warning labels advising young people not to use them.
Aspirin Linked to Lower Melanoma Risk in Study
A study of women ages 50 to 79 has found that taking aspirin is associated with a lower risk of melanoma skin cancer.
Cancer Can Be Treated During Pregnancy
When a pregnant woman is diagnosed with cancer, her treatment decisions are complicated by concern about how treatment may affect the baby’s health.
Rates of Melanoma Deaths Differ by Education
A new study from the American Cancer Society found that declines in deaths from melanoma, a kind of skin cancer, are limited to those with the most education.
Bang! Zap! Pow!
The newest graphic novel in a series designed to explain cancer to children depicts superhero medical experts and cartoon cancer cells.
Ipilimumab Approved for Melanoma
The FDA has approved the drug ipilimumab for advanced melanoma, the most serious form of skin cancer.